Pfizer has declared a quarterly dividend of $0.43 per share for Q2 2025, marking its 346th consecutive quarter of payouts.

Wall Street’s Evan David Seigerman stirred the pot by slashing his price target on Eli Lilly stock—but not his enthusiasm.

Tesla teased investors with a promise of a new low-cost model by mid-2025, sparking initial excitement—until details emerged.

Natixis has significantly reduced its investment in Bank of America, trimming its stake by nearly 23% in the fourth quarter.

Procter & Gamble saw a significant shakeup in shareholder activity, especially as Ossiam slashed its holdings by more than ...

First Trust Advisors LP beefed up its stake in Home Depot by snagging nearly 32,000 more shares, now owning 680,703 in total.

First Trust Advisors LP expanded its Walmart holdings by 238,714 shares, now totaling just under 3 million shares valued at ...

Representative Robert Bresnahan, Jr. of Pennsylvania recently ditched some Meta Platforms shares, selling between $1,001 and ...

Tower Research Capital gave Johnson & Johnson’s portfolio a serious vitamin boost, increasing its stake by 71.4% in Q4. The ...

Ossiam offloaded nearly half of its JPMorgan Chase holdings in Q4, selling 33,181 shares and trimming its position to 33,666 ...

Morgan Stanley just slapped a cold compress on UnitedHealth Group, trimming its price target from $664 to $563 while still ...

Trajan Wealth LLC bulked up its Chevron stake by 7.6%, adding 2,372 shares and pushing its total to a 33,567-share pool worth ...